Product Information

EVEROLIMUS 0.5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $2.9773 per EA under NDC 51991038006. Its NADAC has been published 176 times since Jul 12, 2023.

FDA first approved this application on May 20, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EVEROLIMUS 0.5 MG TABLET

Everolimus tablets
$2.9773per EA

Strength

.5 mg/1

NDC

51991038006

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA205432

FDA Approved

5/20/2021

TE Code

AB

On Market Since

5/21/2021

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for EVEROLIMUS 0.5 MG TABLET has been published 176 times since Jul 12, 2023, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9773 per EA
All-time high$10.1199 (Apr 10, 2024)
All-time low$2.9773 (Nov 18, 2026)
52-week high$4.2997
52-week low$2.9773
Median price$4.6219
Average price$5.0244
Largest weekly change+47.4% (Mar 20, 2024)
Weeks tracked176
Tracking sinceJul 12, 2023

Price History

1W

-7.0%

1M

-15.5%

3M

-20.7%

6M

-17.4%

1Y

-30.8%

3Y

-50.8%

5Y

N/A

All

-41.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EVEROLIMUS 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $2.9773 per EA (NDC 51991038006), effective Nov 18, 2026.

How has the price of EVEROLIMUS 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for EVEROLIMUS 0.5 MG TABLET has declined 41.3%. It has been tracked across 176 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.5 MG TABLET?

Since Jul 12, 2023, the NADAC for EVEROLIMUS 0.5 MG TABLET has ranged from a low of $2.9773 (Nov 18, 2026) to a high of $10.1199 (Apr 10, 2024), with a median of $4.6219 per EA.

Are there cheaper alternatives to EVEROLIMUS 0.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EVEROLIMUS 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures EVEROLIMUS 0.5 MG TABLET?

EVEROLIMUS 0.5 MG TABLET (NDC 51991038006) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.